Who are N acetyl cysteine with weight reduction's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/n-acetyl-cysteine-with-weight-reduction.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

N acetyl cysteine with weight reduction — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

N acetyl cysteine with weight reduction (N acetyl cysteine with weight reduction) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antioxidant with lifestyle intervention. Area: Metabolic/Endocrinology.

phase 3 Antioxidant with lifestyle intervention Glutathione synthesis pathway; indirect metabolic targets via weight reduction Metabolic/Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

N acetyl cysteine with weight reduction (N acetyl cysteine with weight reduction) — Ain Shams University. N-acetyl cysteine replenishes glutathione stores and provides antioxidant support while weight reduction interventions decrease metabolic burden and improve insulin sensitivity.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
N acetyl cysteine with weight reduction TARGET	N acetyl cysteine with weight reduction	Ain Shams University	phase 3	Antioxidant with lifestyle intervention	Glutathione synthesis pathway; indirect metabolic targets via weight reduction

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antioxidant with lifestyle intervention class)

Ain Shams University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). N acetyl cysteine with weight reduction — Competitive Intelligence Brief. https://druglandscape.com/ci/n-acetyl-cysteine-with-weight-reduction. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab